Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Sionna Therapeutics, Inc. (SION) had Stock-Based Compensation of $6.55M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-26.78M |
|
-- |
|
-- |
|
$29.60M |
|
$-29.60M |
|
$2.82M |
|
$-26.78M |
|
$-26.78M |
|
$-26.78M |
|
$-26.78M |
|
$-26.78M |
|
$-26.78M |
|
$-29.60M |
|
$-29.64M |
|
44.92M |
|
44.92M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$220.96M |
|
$2.07M |
|
$84.08M |
|
$305.04M |
|
$9.78M |
|
-- |
|
$7.05M |
|
$16.83M |
|
$288.21M |
|
$288.21M |
|
$288.21M |
|
45.08M |
|
| Cash Flow Statement Financials | |
$-21.84M |
|
$24.82M |
|
$1.89M |
|
$59.41M |
|
$64.29M |
|
$4.87M |
|
|
Stock-Based Compensation |
$6.55M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.60 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.29% |
|
-9.29% |
|
-8.78% |
|
-9.29% |
|
$6.39 |
|
$-0.49 |
|
$-0.49 |
|